References
- Drummond M, Dubois D, Garattini L et al Current trends in the use of pharmacoeconomics and outcome research in Europe. Value Health 2, 323–332 (1999).
- McAlister FA, Strauss SE, Guyatt GH, Haynes RB. User's guides to the medical literature. XX. Integrating research evidence with the care of the individual patient. Evidence based medicine working group. JAMA 283, 2829–2836 (2000).
- •Describes how evidence-based medicine may be used as a methodology to help in the allocation of resources with the advantages and limitation of its use.
- Rosenberg W Donald A. Evidence-based medicine: an approach to clinical problem-solving. BE Med 310, 1122–1126 (1995).
- Sackett D, Rosenberg W Muir JA, Haynes RB, Richardson WS. Evidence-based medicine: what it is and what it isn't. BE Med 311, 71–72 (1996).
- Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. JAIVIA 276, 1172–1177 (1996).
- •Discusses the main role of cost- effectiveness analysis in properly allocating available resources.
- Neumann PJ, Sandberg EA, Bell CM, Stone PW, Chapman RII. Are pharmaceuticals cost-effective? A review of the evidence. Health Affairs 19, 92–109 (2000).
- Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds). Cost-effectiveness in health and medicine. Oxford University Press, Oxford, UK (1996).
- Mason J, Drummond M, Torrance G. Somre guidelines on the use of cost-effectiveness league tables. BE Med. J. 306, 570–572 (1993).
- Drummond M, Torrance G, Mason J. Cost- effectiveness league tables: more harm than good? Soc Sci Med 37, 33–40 (1993).
- ••Review of the pros and cons of the routineuse of league tables to rank available therapeutic alternatives and also gives recommendations to improve their quality and validity. toChapman RII, Stone PW, Sandberg EA, Bell C, Neumann PJ. A comprehensive league table of cost-utility ratios and a sub-table of 'panel-worthy' studies. Med. Decis. Making 20, 451–467 (2000).
- •This study describes the elaboration of league tables based on the efficiency of treatments for many diseases and discusses how to improve their usefulness in daily medical practice. itTengs TO. An evaluation of Oregon's Medicaid rationing algorithms. Health Econ. 5, 171–181 (1996).
- Weinstein MC, Siegel JE, Gold, Amlet MS, Russell LB for the panel on cost-effectiveness in health and medicine. Recommendations of the panel on cost-effectiveness in health and medicine. JA1VIA 276, 1253–1258 (1996).
- •Describes the rationale and principles of using reference-case to transmit the results of cost-effectiveness and how it should be built.
- Drummond ME A reappraisal of economic evaluations of pharmaceuticals. Science or marketing? PharmacoEconomics 14, 1–9 (1998).
- Gerard K, Mooney G. QALY league tables: handle with care. Health Econ. 2, 59–64 (1993).
- •Describes problems and limitations in using league tables for medical decision-making.
- Birch S, Gafni A. Cost-effectiveness ratios: in a league of their own. Health Policy 28, 133–141 (1994).
- Haclorn DC. Setting healthcare priorities in Oregon: cost-effectiveness meets the rule of rescue. JAM4265, 2218–2225 (1991).
- Mason JM. Cost-per-QALY league tables. Their role in pharmacoeconomic analysis. PharmacoEconomics 5, 472–481 (1994).
- •Gives recommendations to create league tables and also review their use in pharmacoeconomic analyses.
- Greenberg PE, Arcelus A, Birnbaum HC et al. Pharmacoeconomics and health policy: current applications and prospects for the future. PharmacoEconomics16, 425–432 (1999).
- Soto J. Efficiency-based pharmacotherapy: the new paradigm for the 21st century in medicine. Eur. j Clin. Pharmacol. 56, 525–527 (2000). Describes briefly the philosophy and utilities of efficiency-based pharrnacotherapy and what principles should be follow in its development.
- O'Brien BJ, Sculpher MJ. Building uncertainty into cost-effectiveness rankings. Portfolio risk-return, tradeoffs and implications for decision rules. Med. Cate 38, 460–468 (2000).
- Hutubessy RCW, Baltussen R, Evans DB, Barendregt JJ, Murray CJL. Stochastic league tables: communicating cost-effectiveness results to decision-makers. Health Econ. 10, 473–477 (2001).